Mercer Global Advisors’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$374K Buy
13,122
+438
+3% +$9.54K ﹤0.01% 2578
2026
Q1
$220K Buy
+12,684
New +$240K ﹤0.01% 2743
2025
Q3
Sell
-22,235
Closed -$434K 2661
2025
Q2
$434K Buy
+22,235
New +$395K ﹤0.01% 1636

Other funds holding CDNA

Mercer Global Advisors's CDNA Position: Q2 2026 in Review

Mercer Global Advisors increased its CareDx (CDNA) stake by 3.5% in Q2 2026, buying an estimated $9.54K and bringing the position to 13,122 shares worth $374K. The position accounts for ﹤0.01% of the portfolio, ranked #2578.

Mercer Global Advisors first reported a position in CDNA in Q2 2025 and has held it in 3 quarters since. The position peaked at $434K in Q2 2025. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

  • Mercer Global Advisors held 13,122 shares of CareDx worth $374K as of Q2 2026.
  • Mercer Global Advisors bought 438 CareDx shares in Q2 2026, an estimated $9.54K.
  • CareDx made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #2578 holding.
  • Mercer Global Advisors first reported a position in CareDx in Q2 2025 and has held it in 3 quarters since.
  • Mercer Global Advisors's CareDx position peaked at $434K in Q2 2025.
  • 227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.